Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study ...Middle East

PR Newswire - News
LUND, Sweden, April 9, 2024 /PRNewswire/ -- Immunovia (NASDAQ: IMMNOV) (STO: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, announces today that the company has successfully developed accurate and precise assays to...

Hence then, the article about immunovia successfully develops assays to measure targeted proteins for its next generation pancreatic cancer test moving forward towards model development study was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News